Thu.Mar 27, 2025

article thumbnail

How Misinformation Has Contributed to Declining Vaccination Rates | APhA 2025

Drug Topics

Lauren Angelo, PharmD, MBA, discussed current vaccination sentiments across the country and how misinformation has contributed to declining rates among US patients.

Vaccines 486
article thumbnail

Cassidy says RFK Jr. briefed him on HHS job cuts, but reported study on vaccines, autism didn’t come up

STAT

WASHINGTON — Sen. Bill Cassidy, the chairman of the Senate health committee, voted to confirm Robert F. Kennedy Jr. as the nation’s health secretary last month on the condition that Kennedy, a longtime vaccine critic, keep him apprised of agency actions, especially those related to vaccines.  On Thursday morning, Cassidy said, the two had breakfast to discuss Kennedy’s plans to lay off 10,000 Health and Human Services Department employees.

Vaccines 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Independent Pharmacies Play Crucial Role in Serving Communities During COVID-19 Pandemic

Drug Topics

Tom DePietro, PharmD, owner of DePietro's Pharmacy, discusses how his pharmacy served their community during the COVID-19 pandemic.

article thumbnail

STAT+: RFK Jr. brings FDA under tighter control with HHS workforce cuts

STAT

WASHINGTON — Around 3,500 employees are on the chopping block at the Food and Drug Administration, but they don’t yet know who they are.  The Health and Human Services Department on Thursday announced a sweeping plan to cut 10,000 jobs and consolidate operations across its sub-agencies. FDA drug, medical device, or food reviewers and inspectors will not be among those fired, according to an HHS fact sheet.

FDA 121
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pharmacists Play Large Role in Continuous Glucose Monitoring for Patients With Diabetes | APhA 2025

Drug Topics

Lindsey Miller, PharmD, clinical assistant professor of pharmacy practice at the University of Mississippi, discusses how pharmacists can help patients understand and effectively use continuous glucose monitoring.

415
415
article thumbnail

STAT+: Two of FDA’s top cancer regulators to depart, heightening worries about drug reviews

STAT

Both deputy directors at the key Food and Drug Administration center that oversees the regulation of cancer drugs plan on departing the agency, sources told STAT Thursday, highlighting the drain on talent at the FDA created by layoffs, uncertainty, and shifts in policy at the agency even as it is set to lay off thousands more people. Both Paul G. Kluetz, who joined the FDA as a medical reviewer in 2016, and Marc R.

FDA 121

More Trending

article thumbnail

Opinion: Former HHS Secretary Donna Shalala on the agency’s ‘silly new bureaucracy’

STAT

When I was secretary of the Department of Health and Human Services under President Bill Clinton, an agency head came to me with a dramatic reorganization plan. I advised him that unless it was data- and outcome-driven, he was wasting his time. Just as important, the reorganization would unsettle and confuse his new colleagues. As a result, his legacy would be a new structure rather than improving people’s lives.

FDA 112
article thumbnail

Once-Weekly Topical Acne Treatment Shows Positive Results in Phase 3 Trial

Drug Topics

Xyngari resulted in significant improvements in IGA treatment success, inflammatory lesion count, and non-inflammatory lesion count compared to placebo.

319
319
article thumbnail

New data show gender-affirming hormones protect from HIV

STAT

Over a decade ago, psychologist and researcher Jae Sevelius had an idea: The behaviors that might put transgender people at particularly high risk of getting HIV stem from the fact that their gender wasn’t being affirmed as they needed.  If that could happen more easily for people — with good medical care, but also through validation from family, friends, and society — they’d be healthier overall, and less likely to engage in risky behavior that could put them at

99
article thumbnail

FDA Approves Denosumab-Bnht as Biosimilar to Prolia, Xgeva

Drug Topics

Denosumab-bnht (Conexxence, Bomyntra) became the third biosimilar in 2025 to be approved for denosumab (Prolia, Xgeva).

FDA 315
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New tests for Alzheimer’s and cancer get FDA’s ‘breakthrough’ status

STAT

A disease detection chatbot powered by generative AI and four cancer tests are among the latest medical devices to receive “breakthrough” status from the Food and Drug Administration. The FDA granted breakthrough designation to devices from at least 15 medical technology companies between December and mid-March, STAT found. You can learn more about these, as well as other devices that have so far received the designation, using STAT’s Breakthrough Device Tracker.

FDA 92
article thumbnail

The Evolution of ChatGPT in Pharmacy Practice

Drug Topics

According to data science expert Don Roosan, PharmD, PhD, the capabilities of ChatGPT are just the beginning of what the future of artificial intelligence may look like in pharmacy practice.

281
281
article thumbnail

How Has Social Media Advertising Changed in Pharma

Pharma Marketing Network

Introduction Social media advertising has undergone a major transformation in the pharmaceutical industry over the past decade. What once was a cautious, slow-moving experiment has now become a vital component of modern pharma marketing strategies. The increasing integration of platforms like LinkedIn, X (formerly Twitter), YouTube, and even TikTok has dramatically shifted how pharma brands engage with healthcare professionals (HCPs), patients, and caregivers.

HIPAA 52
article thumbnail

Q&A: Challenges, Opportunities in Pharmacist-Administered Contraception

Drug Topics

Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, discusses how pharmacists can implement an injectable contraception program.

281
281
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Diabetic Testing Supplies: Don’t Get Burned

DiversifyRx

Dont Get Burned: What Every Pharmacy Owner Needs to Know About Diabetic Testing Supplies Lets talk about something thats come up in multiple conversations with pharmacy owners latelyand its a topic you cant afford to ignore: diabetic testing supplies. Whether youre billing Medicare, selling to cash patients, or stocking your shelves for convenience, diabetic testing supplies can be a reliable source of revenue.

article thumbnail

Advanced Dressings for Comfort & Protection

Drug Topics

Sponsored Content: This video is sponsored by Molnlycke.

247
247
article thumbnail

HHS announces sweeping reorganization, including cuts of 10K workers

PharmaVoice

Along with shrinking the HHS’ workforce further, the reorganization announced Thursday will cut the department from 28 divisions to 15, and close five regional offices.

130
130
article thumbnail

Vaccines Show Efficacy, Safety in Preventing Diseases | APhA 2025

Drug Topics

Kelly Goode, PharmD, BCPS, FAPhA, FCCP, professor in the department of pharmacotherapy and outcomes science at Virginia Commonwealth University, discusses the current landscape of immunization recommendations.

Vaccines 247
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

PharmaVoice

After Tezspire reduced the need for nasal polyp surgery by 98% in patients with a severe respiratory condition, the biopharma giants are even more ambitious for the next wave of biologic medicines.

130
130
article thumbnail

Do AI scribes help health systems save time?

STAT

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Earlier this week, the Peterson Health Technology Institute (PHTI) issued a report that assesses health systems’ experience with AI ambient scribes so far and zeroing in on the technology’s “financial and operational implications.

57
article thumbnail

The case for immigration concessions: maintaining the UK’s competitiveness in science and technology

European Pharmaceutical Review

As scientific and pharmaceutical companies grapple to secure the worlds best talent, the science and immigration sectors are aware that the UKs ability to attract global talent in science and technology is constantly under question. The House of Lords Science and Technology Committee recently warned that the country is in a global competition for talent and that its visa system risks holding it back.

article thumbnail

Five of EU-27 account for 68% of pharma trade, report finds

Pharmafile

Logista Freight has found that Germany, France, Belgium, Italy and the Netherlands account for up to 68% of trade in pharmaceutical products in the EU-27. Furthermore, trade from Ireland to Belgium, from Germany to the Netherlands and from the Netherlands to Germany occupy the highest trade positions. Logista Freight is a logistics company which specialises […] The post Five of EU-27 account for 68% of pharma trade, report finds appeared first on Pharmafile.

59
article thumbnail

The Healthcare Businesswomen’s Association (HBA) Announces its 2025 Rising Star and Luminary Honorees

Pharma Marketing Network

The Healthcare Businesswomens Association (HBA) has proudly announced its 2025 class of Rising Star and Luminary honorees! Nominated by the HBAs Corporate Partners, these leaders are not only exceptional contributors within their companies but also powerful advocates for health equity and women’s advancement globally, significantly contributing to the HBAs vision of Creating Women Leaders for Life.

article thumbnail

Contrave alternatives: What can I take instead?

The Checkup by Singlecare

Contrave extended-release tablets are a brand-name prescription medication approved by the U.S. Food and Drug Administration (FDA) for weight management in adults who are overweight or obese. Contrave contains two medicines (naltrexone, an opioid antagonist, and bupropion, an antidepressant medicine) intended to be used along with a reduced-calorie diet and increased physical activity to help lose weight.

article thumbnail

Dupilumab Associated With Reduction of Food-Specific IgEs at 12, 24 Months

Pharmacy Times

At 12 and 24 months, there were 56.9% and 73.5% reductions in food-specific immunoglobulin E (IgE).

122
122
article thumbnail

STAT+: Burst PIPEs? So-so returns for biotech’s once-buzzy financing vehicle

STAT

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. This is the one-year anniversary edition of the Biotech Scorecard newsletter!  I have poured my heart and soul into this endeavor. It’s been immensely gratifying, and I’m deeply grateful to all of you for the attention you’ve given it over the past 12 months.

64
article thumbnail

Leveraging Technology to Enhance Women’s Health and Access to Care

Pharmacy Times

Panelists discuss how digital health technologies revolutionize womens health care through telehealth, mobile apps, and remote monitoring, expanding access, personalization, and proactive medical support.

116
116
article thumbnail

Are you affected by the HHS cuts and restructuring?

STAT

The Health and Human Services Department is set to cut 10,000 jobs and consolidate divisions under Secretary Robert F. Kennedy Jr. We are eager to hear from readers who have been impacted by the mass layoffs and restructuring at the agency and others under its umbrella.

FDA 112
article thumbnail

Denosumab-bnht Biosimilar Receives FDA Approval

Pharmacy Times

The biosimilar is approved for all indications of the reference products, Prolia and Xgeva.

FDA 100
article thumbnail

Blockbuster potential drugs ruled the 2024 pipeline with 53% rise over 2023

Pharmaceutical Technology

GLP-1RAs were the big game changer, boosting average forecast sales and return on investment rates.

98
article thumbnail

FDA fast-tracks Sanofi's experimental chlamydia vaccine

pharmaphorum

Sanofi is preparing to start human testing of its chlamydia vaccine, now fast-tracked by the FDA, that it hopes will be the first to reach the market.

article thumbnail

NIH director targets misinformation research as more turmoil rocks health agencies 

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Let’s get straight into the news today.

81
article thumbnail

FDA clears first treatment for Prader-Willi syndrome

pharmaphorum

Soleno Therapeutics' Vykat XR has become the first FDA-approved treatment for excessive eating in rare disorder Prader-Willi syndrome.

FDA 93